Literature DB >> 26098703

Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy.

Xian-Chun Tang1, Wayne A Marasco1.   

Abstract

Entities:  

Keywords:  IGHV1–69; MERS-CoV; animal model; biodefense; emerging pathogen; human monoclonal antibodies; humoral immunity; passive immunotherapy; spike protein; zoonosis

Mesh：

Substances：

Year:  2015        PMID： 26098703      PMCID： PMC5068219          DOI： 10.2217/imt.15.33

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  15 in total

1.  Treatment of severe acute respiratory syndrome with convalescent plasma.

Authors:  V W S Wong; D Dai; A K L Wu; J J Y Sung
Journal:  Hong Kong Med J       Date:  2003-06       Impact factor: 2.227

2.  Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.

Authors:  Julie Dyall; Christopher M Coleman; Brit J Hart; Thiagarajan Venkataraman; Michael R Holbrook; Jason Kindrachuk; Reed F Johnson; Gene G Olinger; Peter B Jahrling; Monique Laidlaw; Lisa M Johansen; Calli M Lear-Rooney; Pamela J Glass; Lisa E Hensley; Matthew B Frieman
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

3.  Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.

Authors:  Adriaan H de Wilde; Dirk Jochmans; Clara C Posthuma; Jessika C Zevenhoven-Dobbe; Stefan van Nieuwkoop; Theo M Bestebroer; Bernadette G van den Hoogen; Johan Neyts; Eric J Snijder
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

4.  Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

Authors:  Tianlei Ying; Lanying Du; Tina W Ju; Ponraj Prabakaran; Candy C Y Lau; Lu Lu; Qi Liu; Lili Wang; Yang Feng; Yanping Wang; Bo-Jian Zheng; Kwok-Yung Yuen; Shibo Jiang; Dimiter S Dimitrov
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

5.  Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.

Authors:  Liwei Jiang; Nianshuang Wang; Teng Zuo; Xuanling Shi; Kwok-Man Vincent Poon; Yongkang Wu; Fei Gao; Danyang Li; Ruoke Wang; Jianying Guo; Lili Fu; Kwok-Yung Yuen; Bo-Jian Zheng; Xinquan Wang; Linqi Zhang
Journal:  Sci Transl Med       Date:  2014-04-28       Impact factor: 17.956

6.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.

Authors:  Xian-Chun Tang; Sudhakar S Agnihothram; Yongjun Jiao; Jeremy Stanhope; Rachel L Graham; Eric C Peterson; Yuval Avnir; Aimee St Clair Tallarico; Jared Sheehan; Quan Zhu; Ralph S Baric; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

7.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

8.  Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques.

Authors:  Darryl Falzarano; Emmie de Wit; Angela L Rasmussen; Friederike Feldmann; Atsushi Okumura; Dana P Scott; Doug Brining; Trenton Bushmaker; Cynthia Martellaro; Laura Baseler; Arndt G Benecke; Michael G Katze; Vincent J Munster; Heinz Feldmann
Journal:  Nat Med       Date:  2013-09-08       Impact factor: 53.440

9.  Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway.

Authors:  Jianhua Sui; Daniel R Aird; Azaibi Tamin; Akikazu Murakami; Meiying Yan; Anuradha Yammanuru; Huaiqi Jing; Biao Kan; Xin Liu; Quan Zhu; Qing-An Yuan; Gregory P Adams; William J Bellini; Jianguo Xu; Larry J Anderson; Wayne A Marasco
Journal:  PLoS Pathog       Date:  2008-11-07       Impact factor: 6.823

10.  Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.

Authors:  Lu Lu; Qi Liu; Yun Zhu; Kwok-Hung Chan; Lili Qin; Yuan Li; Qian Wang; Jasper Fuk-Woo Chan; Lanying Du; Fei Yu; Cuiqing Ma; Sheng Ye; Kwok-Yung Yuen; Rongguang Zhang; Shibo Jiang
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919
View more
  2 in total

1.  Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.

Authors:  Peihua Niu; Senyan Zhang; Panpan Zhou; Baoying Huang; Yao Deng; Kun Qin; Pengfei Wang; Wenling Wang; Xinquan Wang; Jianfang Zhou; Linqi Zhang; Wenjie Tan
Journal:  J Infect Dis       Date:  2018-09-08       Impact factor: 5.226

2.  Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.

Authors:  Jean-Louis Excler; Christopher J Delvecchio; Ryan E Wiley; Marni Williams; In-Kyu Yoon; Kayvon Modjarrad; Mohamed Boujelal; Vasee S Moorthy; Ahmad Salah Hersi; Jerome H Kim
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.